Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

INTRODUCTION: Metaplastic breast carcinomas constitute a heterogeneous group of neoplasms, accounting for less than 1% of all invasive mammary carcinomas. Approximately 70–80% of metaplastic breast carcinomas overexpress the epidermal growth factor receptor (EGFR). Human epidermal growth factor rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis-Filho, Jorge S, Milanezi, Fernanda, Carvalho, Silvia, Simpson, Pete T, Steele, Dawn, Savage, Kay, Lambros, Maryou BK, Pereira, Emilio M, Nesland, Jahn M, Lakhani, Sunil R, Schmitt, Fernando C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410747/
https://www.ncbi.nlm.nih.gov/pubmed/16280056
http://dx.doi.org/10.1186/bcr1341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410747/
https://www.ncbi.nlm.nih.gov/pubmed/16280056
http://dx.doi.org/10.1186/bcr1341

Ejemplares similares